JP2018531287A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531287A5 JP2018531287A5 JP2018537732A JP2018537732A JP2018531287A5 JP 2018531287 A5 JP2018531287 A5 JP 2018531287A5 JP 2018537732 A JP2018537732 A JP 2018537732A JP 2018537732 A JP2018537732 A JP 2018537732A JP 2018531287 A5 JP2018531287 A5 JP 2018531287A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- nhco
- formula
- conh
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JVERXSWAVSISQC-UHFFFAOYSA-N C=C=C[IH]CC(CN)CF Chemical compound C=C=C[IH]CC(CN)CF JVERXSWAVSISQC-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1517859.3 | 2015-10-08 | ||
| GBGB1517859.3A GB201517859D0 (en) | 2015-10-08 | 2015-10-08 | Novel compounds and therapeutic uses thereof |
| PCT/GB2016/053134 WO2017060729A1 (en) | 2015-10-08 | 2016-10-07 | Compounds and therapeutic uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2018531287A JP2018531287A (ja) | 2018-10-25 |
| JP2018531287A6 JP2018531287A6 (ja) | 2018-12-13 |
| JP2018531287A5 true JP2018531287A5 (cg-RX-API-DMAC7.html) | 2019-11-21 |
| JP7065775B2 JP7065775B2 (ja) | 2022-05-12 |
Family
ID=55130801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018537732A Active JP7065775B2 (ja) | 2015-10-08 | 2016-10-07 | 化合物及びそれらの治療用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10953100B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3359201A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7065775B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108472381B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016335365B2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201517859D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL258511B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2017060728A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201802256B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019002879A (es) | 2016-09-13 | 2019-09-18 | Centauri Therapeutics Ltd | Compuestos novedosos y usos terapeuticos de los mismos. |
| GB201707076D0 (en) * | 2017-05-04 | 2017-06-21 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| GB201705686D0 (en) * | 2017-04-07 | 2017-05-24 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| GB201705684D0 (en) * | 2017-04-07 | 2017-05-24 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| GB201707079D0 (en) | 2017-05-04 | 2017-06-21 | Centauri Therapeutics Ltd | Novel compounds and therapeutics uses thereof |
| GB201816554D0 (en) * | 2018-10-10 | 2018-11-28 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| CN111748089B (zh) * | 2019-03-28 | 2023-07-18 | 成都先导药物开发股份有限公司 | 一种生物素标记化合物以及确定化合物结合靶标蛋白的方法 |
| CN116535449B (zh) * | 2023-03-22 | 2025-09-16 | 华东理工大学 | 一种糖基没食子酸类衍生物及其制备方法与在制备乳腺癌靶向诊疗材料中的应用 |
| GB202406865D0 (en) | 2024-05-15 | 2024-06-26 | Centauri Therapeutics Ltd | Novel compounds and therapeutics uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6172045B1 (en) | 1994-12-07 | 2001-01-09 | Neorx Corporation | Cluster clearing agents |
| US7645743B2 (en) | 1999-12-22 | 2010-01-12 | Altermune, Llc | Chemically programmable immunity |
| EP2322209A3 (en) | 2002-08-20 | 2012-02-01 | Glykos Finland Oy | Tumor specific oligosaccharide epitopes and use thereof |
| JP4430344B2 (ja) * | 2002-09-09 | 2010-03-10 | 独立行政法人科学技術振興機構 | 多岐用途型リンカー化合物及びリガンド、並びにそれらの製造方法 |
| EP1653977A2 (en) | 2003-07-17 | 2006-05-10 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Treatment of disorders associated with natural killer t cells |
| CN101360728A (zh) * | 2005-10-25 | 2009-02-04 | 艾吉拉医疗股份有限公司 | Iap bir结构域结合化合物 |
| US7998486B2 (en) | 2006-10-25 | 2011-08-16 | Newlink Genetics Corporation | Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes |
| CN102459298A (zh) * | 2009-05-05 | 2012-05-16 | 阿尔特姆恩科技责任有限公司 | 化学可编程免疫 |
| US9636419B2 (en) * | 2013-10-11 | 2017-05-02 | The Universit of Kansas | Targeting multiple receptors on a cell surface for specific cell targeting |
| GB201411150D0 (en) * | 2014-06-23 | 2014-08-06 | Altermune Technologies Llc | Novel aptamers and therapeutic uses thereof |
-
2015
- 2015-10-08 GB GBGB1517859.3A patent/GB201517859D0/en not_active Ceased
-
2016
- 2016-10-07 EP EP16781531.5A patent/EP3359201A1/en active Pending
- 2016-10-07 CN CN201680071566.0A patent/CN108472381B/zh active Active
- 2016-10-07 WO PCT/GB2016/053133 patent/WO2017060728A1/en not_active Ceased
- 2016-10-07 AU AU2016335365A patent/AU2016335365B2/en active Active
- 2016-10-07 US US15/766,193 patent/US10953100B2/en active Active
- 2016-10-07 JP JP2018537732A patent/JP7065775B2/ja active Active
- 2016-10-07 WO PCT/GB2016/053134 patent/WO2017060729A1/en not_active Ceased
-
2018
- 2018-04-05 IL IL258511A patent/IL258511B/en unknown
- 2018-04-06 ZA ZA2018/02256A patent/ZA201802256B/en unknown
-
2021
- 2021-03-01 US US17/188,532 patent/US20210369850A1/en not_active Abandoned